Severe allergic asthma paediatric - omalizumab - initial authority application form (PB188)

Use this form to apply for initial PBS-subsidised treatment with omalizumab for patients 6 to under 12 years with uncontrolled severe allergic asthma.

Page last updated: 1 July 2024.
QC 35876